Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review

Date: April 26, 2016
Pages: 85
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TF26C67256DEN
Leaflet:

Download PDF Leaflet

Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review
Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Teva Pharmaceutical Industries Ltd. (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and generic medicines in various forms such as capsules, tablets, ointments, liquids, creams, injectables and inhalants. The company offers specialty pharmaceuticals in central nervous system, respiratory, cancer and women’s health. Teva also provides over-the-counter (OTC) products through a joint venture with P&G in Israel and Hungary. It has operations in United States, Europe and Rest of the World (Japan, Canada, Venezuela and Russia). Teva is headquartered in Tikva, Israel.

Teva Pharmaceutical Industries Ltd. Key Recent Developments

Mar 31, 2016: Takeda and Teva Establish “Teva Takeda Yakuhin” in Japan
Feb 24, 2016: Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global Brand
Feb 11, 2016: Teva Reports Full Year 2015 and Fourth Quarter Financial Results
Jan 25, 2016: Teva Releases Innovation and Social Responsibility Highlights
Nov 19, 2015: Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Teva Pharmaceutical Industries Ltd. - Key Facts
    Teva Pharmaceutical Industries Ltd. - Key Employees
    Teva Pharmaceutical Industries Ltd. - Key Employee Biographies
    Teva Pharmaceutical Industries Ltd. - Major Products and Services
    Teva Pharmaceutical Industries Ltd. - History
    Teva Pharmaceutical Industries Ltd. - Company Statement
    Teva Pharmaceutical Industries Ltd. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Teva Pharmaceutical Industries Ltd. - Business Description
    Teva Pharmaceutical Industries Ltd. - Corporate Strategy
    Teva Pharmaceutical Industries Ltd. - SWOT Analysis
    SWOT Analysis - Overview
    Teva Pharmaceutical Industries Ltd. - Strengths
    Strength - Strong Presence - Central Nervous System Market
    Strength - Dominant Market Position
    Strength - Research and Development Activities
    Teva Pharmaceutical Industries Ltd. - Weaknesses
    Weakness - Declining Profitability
    Weakness - Discontinued Projects
    Teva Pharmaceutical Industries Ltd. - Opportunities
    Opportunity - Inorganic Growth: Acquisitions
    Opportunity - Product Launches in US Market
    Opportunity - Strategic Partnerships
    Teva Pharmaceutical Industries Ltd. - Threats
    Threat - Industry Regulations
    Threat - Competitive Pressures
    Threat - Dependence on Major Customers
    Teva Pharmaceutical Industries Ltd. - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals By Type, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Mar 31, 2016: Takeda and Teva Establish “Teva Takeda Yakuhin” in Japan
    Feb 24, 2016: Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global Brand
    Feb 11, 2016: Teva Reports Full Year 2015 and Fourth Quarter Financial Results
    Jan 25, 2016: Teva Releases Innovation and Social Responsibility Highlights
    Nov 19, 2015: Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease
    Nov 02, 2015: Teva’s Statement on its Internal Specialty Pharmacy
    Oct 29, 2015: Teva Reports Third Quarter 2015 Results
    Sep 10, 2015: Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
    Sep 08, 2015: Teva Introduces “Design for Dialogue” to Support Patient-Doctor Conversations on Responsible Pain Management
    Jul 30, 2015: Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Teva Pharmaceutical Industries Ltd., Key Facts
    Teva Pharmaceutical Industries Ltd., Key Employees
    Teva Pharmaceutical Industries Ltd., Key Employee Biographies
    Teva Pharmaceutical Industries Ltd., Major Products and Services
    Teva Pharmaceutical Industries Ltd., History
    Teva Pharmaceutical Industries Ltd., Subsidiaries
    Teva Pharmaceutical Industries Ltd., Joint Venture
    Teva Pharmaceutical Industries Ltd., Key Competitors
    Teva Pharmaceutical Industries Ltd., Ratios based on current share price
    Teva Pharmaceutical Industries Ltd., Annual Ratios
    Teva Pharmaceutical Industries Ltd., Interim Ratios
    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals By Type, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Teva Pharmaceutical Industries Ltd., Performance Chart (2011 - 2015)
    Teva Pharmaceutical Industries Ltd., Ratio Charts
    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
    Teva Pharmaceutical Industries Ltd., Medical Equipment, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: